A novel, non-invasive approach to determining fractional flow reserve failed to show sufficient diagnostic accuracy to meet the primary endpoint of the DeFACTO trial, but was more accurate for diagnosing coronary artery ischemia than computed tomography, reported the trial’s lead investigator.
viaMedWire News
viaMedWire News
No comments:
Post a Comment